Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients.

Trial Profile

Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Letrozole (Primary) ; Cetrorelix; Chorionic gonadotropin; Follitropin alfa; Menotropin; Triptorelin
  • Indications Breast cancer; Female infertility
  • Focus Therapeutic Use
  • Acronyms BROVALE
  • Most Recent Events

    • 09 Feb 2018 Planned end date changed from 1 Dec 2021 to 1 Dec 2022.
    • 09 Feb 2018 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top